Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Jiangxi Institute of Biological Products OCF Yield %?
Jiangxi Institute of Biological ProductsHKSE:06915 +1.33%23 OCF Yield % is 1.22 as of Sep. 10, 2026, which is 16% below its 10-year median of 1.45. GuruFocus rates HKSE:06915 with a GF Score™ of 23/100. The stock has 3 warning signs investors should review. Among 1,005 Drug Manufacturers companies, Jiangxi Institute of Biological Products ranks worse than 63.18% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Jiangxi Institute of Biological Products OCF Yield % Explanation
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Jiangxi Institute of Biological Products OCF Yield % Related Terms
Jiangxi Institute of Biological Products OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangxi Institute of Biological Products OCF Yield % Chart
Jiangxi Institute of Biological Products Annual Data
Trend
Dec23
Dec24
Dec25
OCF Yield %
0.00
0.00
0.00
Jiangxi Institute of Biological Products Semi-Annual Data
Dec23
Dec24
Dec25
OCF Yield %
0.00
0.00
0.00
HKSE:06915 vs LLY, JNJ, ABBV: OCF Yield % Comparison
For the Drug Manufacturers - General subindustry, Jiangxi Institute of Biological Products's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jiangxi Institute of Biological Products OCF Yield % vs Drug Manufacturers Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangxi Institute of Biological Products (HKSE:06915) has a OCF Yield % of 1.22 as of Sep. 10, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Jiangxi Institute of Biological Products and its competitors. This is 16% below median its historical median of 1.45. Over the past decade, Jiangxi Institute of Biological Products' OCF Yield % has ranged from 0.99 to 4.53. According to the industry distribution chart, Jiangxi Institute of Biological Products ranks #635 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 63.2%.
Is Jiangxi Institute of Biological Products' OCF Yield % too high?
Jiangxi Institute of Biological Products' current OCF Yield % of 1.22 is 16% below median its 10-year median of 1.45. Over the past 10 years, this metric has ranged from a low of 0.99 to a high of 4.53. The Drug Manufacturers industry median OCF Yield % is 3.45. Jiangxi Institute of Biological Products' value of 1.22 is 64.6% below this industry median. Based on the distribution chart, Jiangxi Institute of Biological Products ranks #635 out of 1005 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Jiangxi Institute of Biological Products has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Jiangxi Institute of Biological Products' OCF Yield % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Jiangxi Institute of Biological Products ranks #635 out of 1005 companies for OCF Yield %. This places Jiangxi Institute of Biological Products in the lower half of its industry. The industry median OCF Yield % is 3.45. Jiangxi Institute of Biological Products' value of 1.22 is 64.6% below this benchmark. Historically, Jiangxi Institute of Biological Products' own OCF Yield % has ranged from 0.99 to 4.53 over the past decade. While the company's 10-year median is 1.45 vs. the industry median of 3.45, Jiangxi Institute of Biological Products has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.45, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jiangxi Institute of Biological Products's current OCF Yield % of 1.22 is 64.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Jiangxi Institute of Biological Products and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jiangxi Institute of Biological Products's current OCF Yield % is 1.22, which is 16% below median its own 10-year median of 1.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangxi Institute of Biological Products stock overvalued right now?
Jiangxi Institute of Biological Products (HKSE:06915) has a current OCF Yield % of 1.22. The current OCF Yield % is 1.22, which is 16% below median its 10-year median of 1.45 and 64.6% below the Drug Manufacturers industry median of 3.45. Jiangxi Institute of Biological Products' overall GF Score™ is 23/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Jiangxi Institute of Biological Products (HKSE:06915), the current OCF Yield % is 1.22 as of Sep. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Jiangxi Institute of Biological Products Inc is principally engaged in the business of research and development, and production and sale of human tetanus antitoxin. It operates as the provider and exporter of Human TAT in China and an antiserum platform company. Its products include biological products containing immunoglobulins or immunoglobulin F(ab')2 fragments, which are used in medical applications such as tetanus, snakebite envenoming, and rabies treatment. The majority of the company's revenue is derived from the sale of Human Tetanus Antitoxin in the Chinese mainland.
23GF Score
Get the complete analysis for HKSE:06915
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:06915 has been successfully added to your 
